Correlation Between Oral Health and Systemic Inflammation (COHESION)
NCT03641989
Gingival Diseases, Gingivitis
Marshfield, Wisconsin, United States
View Trial DetailsNCT Number: NCT02848378
This study investigates the levels of advanced oxidation protein product and monocyte chemoattractant protein-1 in gingival crevicular fluid in periodontal disease and health. 25 participants with chronic periodontitis, 25 participants with gingivitis and 25 periodontally healthy subjects are included into this study. In each participant, four sites are identified for gingival crevicular fluid samples.
Looking for future studies?
Notify Me18 year–66 year
All sexes
Observational
Oxidative stress is the disequilibrium between the formation of free radicals and antioxidant defense mechanisms via damaging cellular macromolecules (DNA, protein, lipid, etc..) which are susceptible to oxidative damage.
Advanced oxidation protein product is identified as a new marker of protein oxidation.
Monocyte chemoattractant protein-1 is a major chemoattractant for lymphocytes, monocytes and macrophages.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Before periodontal treatment
Time frame: Before periodontal treatment
Time frame: Before periodontal treatment
Kırıkkale University
Other
The Levels of Advanced Oxidation Protein Product and Monocyte Chemoattractant Protein-1 in Gingival Crevicular Fluid in Periodontal Disease and Health
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03641989
Gingival Diseases, Gingivitis
Marshfield, Wisconsin, United States
View Trial DetailsNCT00379548
Cardiovascular Disease, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07272564
Inflammation, Mouth Diseases
Istanbul, Fatih, Turkey (Türkiye)
View Trial DetailsNCT06906510
Inflammation, Mouth Diseases
Istanbul, Fatih, Turkey (Türkiye)
View Trial Details